Product name:Bevacizumab ( 贝伐珠单抗 )

Catalog No. : FrdE00012

MW:149000.00 Da

Description:Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab, a humanized monoclonal antibody,specifically binds to all VEGF-A isoforms with high affinity.

Alternative names:Bevacizumab

Specificity target name;species:VEGFA[Homo sapiens]

Form: Liquid

Receptor identification:IgG1-kappa

Storage: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt.

Purity:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Note: This product is for research use only,not for diagnostic or therapeutic use.